1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Turkey Pharmaceuticals and Healthcare Report Q2 2016

Turkey Pharmaceuticals and Healthcare Report Q2 2016

  • April 2016
  • -
  • Business Monitor International
  • -
  • 85 pages

Includes 3 FREE quarterly updates

BMI View: A strong healthcare sector and more certain drug pricing policy will drive pharmaceutical salesin value terms over the next 10 years and improve the commercial opportunities for pharmaceuticalmanufacturers. Despite this positive development, cost containment measures will remain a risk, as will thepolitical situation with neighbouring Syria and nearby Russia.

Headline Expenditure Projections

- Pharmaceuticals: TRY20.81bn (USD7.64bn) in 2015 to TRY23.21bn (USD7.54bn) in 2016; +11.5% inlocal currency and -1.4% US dollar terms. Forecast unchanged in local currency and up in US dollarscompared with previous quarter due to revised exchange rate expectations.

- Healthcare: TRY107.17bn (USD39.38bn) in 2015 to TRY120.16bn (USD39.01bn) in 2016; +2.7% inlocal currency and -0.9% US dollar terms. Forecast unchanged in local currency and up in US dollarscompared with previous quarter due to revised exchange rate expectations.

Table Of Contents

Turkey Pharmaceuticals and Healthcare Report Q2 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Turkey 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Turkey 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Turkey 2012-2020) 15
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Turkey 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Turkey 2012-2020) 16
Prescription Drug Market Forecast 17
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Turkey 2012-2020) 18
Patented Drug Market Forecast 19
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Turkey 2012-2020) 20
Generic Drug Market Forecast 21
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Turkey 2012-2020) 22
OTC Medicine Market Forecast 23
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Turkey 2012-2020) 24
Pharmaceutical Trade Forecast 25
Table: Pharmaceutical Trade Data And Forecasts (Turkey 2014-2020) 26
Table: Pharmaceutical Trade Data And Forecasts local currency (Turkey 2014-2020) 27
Industry Risk/Reward Index 28
Central And Eastern Europe Risk/Reward Index 28
Turkey Risk/Reward Index 34
Rewards 34
Risks 35
Regulatory Review 36
Intellectual Property Regime 36
Pricing Regime 39
Reimbursement Regime 40
Market Overview 41
Healthcare Sector 42
Table: Healthcare Resources (Turkey 2010-2015) 45
Table: Healthcare Personnel (Turkey 2010-2015) 45
Table: Healthcare Activity (Turkey 2010-2015) 46
Research and Development 46
Clinical Trials 47
Epidemiology 48
Competitive Landscape 51
Pharmaceutical Sector 51
Research-Based Industry 52
Generic Drugmakers 53
Table: Multinational Market Activity 55
Pharmaceutical Distribution 56
Pharmaceutical Retail 57
Company Profile 58
Abdi ?brahim 58
EastPharma (Deva) 62
Eczaciba?i Healthcare 65
Mustafa Nevzat Ilac Sanayi (MN) Pharmaceuticals 68
Sanovel Pharmaceuticals 71
Demographic Forecast 74
Table: Population Headline Indicators (Turkey 1990-2025) 75
Table: Key Population Ratios (Turkey 1990-2025) 75
Table: Urban/Rural Population and Life Expectancy (Turkey 1990-2025) 76
Table: Population By Age Group (Turkey 1990-2025) 76
Table: Population By Age Group % (Turkey 1990-2025) 77
Glossary 79
Methodology 81
Pharmaceutical Expenditure Forecast Model 81
Healthcare Expenditure Forecast Model 81
Notes On Methodology 82
Risk/Reward Index Methodology 83
Index Overview 84
Table: Pharmaceutical Risk/Reward Index Indicators 84
Indicator Weightings 85

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.